Bayhill Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus (NCT00453375) | Bayhill Therapeutics | 2006-10-01 |
| BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis (NCT00382629) | Bayhill Therapeutics | 2006-02-01 |
| Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis (NCT00103974) | Bayhill Therapeutics | 2004-07-01 |
Track Bayhill Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.